Xvivo Perfusion Balance Sheet Health
Financial Health criteria checks 6/6
Xvivo Perfusion has a total shareholder equity of SEK2.0B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK2.3B and SEK250.5M respectively. Xvivo Perfusion's EBIT is SEK13.2M making its interest coverage ratio -5.7. It has cash and short-term investments of SEK511.2M.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | -5.7x |
| Cash | kr511.15m |
| Equity | kr2.00b |
| Total liabilities | kr250.54m |
| Total assets | kr2.25b |
Recent financial health updates
No updates
Recent updates
Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 25
There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital
Apr 11Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates
Feb 05We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings
Feb 01Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jan 28Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled
Aug 24Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching
Jul 17Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?
Jun 16Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital
Apr 19Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?
Mar 23With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case
Mar 07When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?
Feb 13Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Dec 14Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?
Nov 17Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively
Aug 20Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are
Jul 21Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Mar 30At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?
Feb 18A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)
Jan 30Calculating The Intrinsic Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)
Apr 09Should You Think About Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Now?
Mar 19What Type Of Shareholders Own The Most Number of Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?
Feb 26Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?
Feb 05Financial Position Analysis
Short Term Liabilities: XVIVO's short term assets (SEK830.7M) exceed its short term liabilities (SEK199.8M).
Long Term Liabilities: XVIVO's short term assets (SEK830.7M) exceed its long term liabilities (SEK50.7M).
Debt to Equity History and Analysis
Debt Level: XVIVO is debt free.
Reducing Debt: XVIVO has no debt compared to 5 years ago when its debt to equity ratio was 1.5%.
Debt Coverage: XVIVO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: XVIVO has no debt, therefore coverage of interest payments is not a concern.